Novartis AG
Utility Patent Applications
Last updated:
List of all Novartis AG patents 676 in total
| Status | Patent |
|---|---|
Application | Utility: LICOFLIGOZIN FOR THE TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS Filling date: 23 Sep 2025 Issue date: 20 May 2021 |
Application | Utility: TREATMENT OF CANCER USING A CD33 CHIMERIC ANTIGEN RECEPTOR Filling date: 23 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: Solid Forms Comprising an Oxime Ether Compound and a Coformer, Compositions and Methods of Use Thereof Filling date: 23 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: CD19 BINDING MOLECULES AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 13 May 2021 |
Application | Utility: Drug Delivery Systems Filling date: 23 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: CYCLODEXTRIN-BASED POLYMERS FOR DELIVERING THE THERAPEUTIC AGENTS COVALENTLY BOUND THERETO Filling date: 23 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: METHODS OF TREATING ANKYLOSING SPONDYLITIS USING IL-17 ANTAGONISTS Filling date: 23 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS Filling date: 23 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: Antiviral Pyrazolopyridinone Compounds Filling date: 23 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: METHODS FOR TREATING DISEASE USING INHIBITORS OF BONE MORPHOGENETIC PROTEIN 6 (BMP6) Filling date: 23 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: COMBINATION OF C-MET INHIBITOR WITH ANTIBODY MOLECULE TO PD-1 AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: REGULATORS OF HUMAN PLURIPOTENT STEM CELLS AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: A TRIPLE PHARMACEUTICAL COMBINATION COMPRISING DABRAFENIB, TRAMETINIB AND AN ERK INHIBITOR Filling date: 23 Sep 2025 Issue date: 29 Apr 2021 |
Application | Utility: METHODS OF TREATING PSORIASIS USING IL-17 ANTAGONISTS Filling date: 23 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES Filling date: 23 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: Tablet Formulation of 2-Fluoro-N-Methyl-4-[7-(Quinolin-6-Ylmethyl) Imidazo [1,2-B] [1,2,4] Triazin-2-YL] Benzamide Filling date: 23 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: METHODS OF TREATING CHRONIC SPONTANEOUS URTICARIA USING LIGELIZUMAB Filling date: 23 Sep 2025 Issue date: 22 Apr 2021 |
Application | Utility: 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS Filling date: 23 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: LABEL-FREE ANALYSIS OF RNA CAPPING EFFICIENCY USING RNASE H, PROBES AND LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY Filling date: 23 Sep 2025 Issue date: 15 Apr 2021 |
Application | Utility: COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE RECEPTORS Filling date: 23 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: Methods for Treating EGFR Mutant Cancers Filling date: 23 Sep 2025 Issue date: 8 Apr 2021 |
Application | Utility: PROCESS FOR CONCENTRATION OF ANTIBODIES AND THERAPEUTIC PRODUCTS THEREOF Filling date: 23 Sep 2025 Issue date: 1 Apr 2021 |
Application | Utility: Methods for Preventing Cardiovascular Events Through Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Reduction Filling date: 23 Sep 2025 Issue date: 1 Apr 2021 |
Application | Utility: USE OF MAVOGLURANT IN THE REDUCTION OF COCAINE USE OR IN PREVENTING RELAPSE INTO COCAINE USE Filling date: 23 Sep 2025 Issue date: 1 Apr 2021 |
Application | Utility: DUAL-ACTING PHARMACEUTICAL COMPOSITIONS BASED ON SUPERSTRUCTURES OF ANGIOTENSIN RECEPTOR ANTAGONIST/BLOCKER (ARB) AND NEUTRAL ENDOPEPTIDASE (NEP) INHIBITOR Filling date: 23 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: Chemical Process for Preparing Imidazopyrrolidinone Derivatives and Intermediates Thereof Filling date: 23 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: REGULATABLE CHIMERIC ANTIGEN RECEPTOR Filling date: 23 Sep 2025 Issue date: 25 Mar 2021 |
Application | Utility: LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS Filling date: 23 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: NEW USE Filling date: 23 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: TREATMENT OF CANCER USING GFR ALPHA-4 CHIMERIC ANTIGEN RECEPTOR Filling date: 23 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: COMBINATION THERAPY Filling date: 23 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: HYDROPHILIC FILTRATION DURING MANUFACTURE OF VACCINE ADJUVANTS Filling date: 23 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: TARGETING CYTOTOXIC CELLS WITH CHIMERIC RECEPTORS FOR ADOPTIVE IMMUNOTHERAPY Filling date: 23 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: ANTI-CD40 ANTIBODIES FOR USE IN PREVENTION OF GRAFT REJECTION Filling date: 23 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: NOVEL DIHYDROISOXAZOLE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF HEPATITIS B Filling date: 23 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: COMPOUNDS AND COMPOSITIONS FOR INDUCING CHONDROGENESIS Filling date: 23 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: MODIFIED RELEASE FORMULATION Filling date: 23 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: HIGH DOSE DELIVERY OF INHALED THERAPEUTICS Filling date: 23 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: METHOD FOR PREPARING GRANULES Filling date: 23 Sep 2025 Issue date: 11 Mar 2021 |
Application | Utility: Method of Adjuvant Cancer Treatment Filling date: 23 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: CARBOXAMIDE DERIVATIVES Filling date: 23 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: METHODS OF TREATING OPHTHALMIC DISORDERS Filling date: 23 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: VIRAL VECTORS FOR THE TREATMENT OF RETINAL DYSTROPHY Filling date: 23 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: CAR T CELL THERAPIES WITH ENHANCED EFFICACY Filling date: 23 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: COMBINATION THERAPY USING A CHIMERIC ANTIGEN RECEPTOR Filling date: 23 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: ANTIBODIES TARGETING CD32B AND METHODS OF USE THEREOF Filling date: 23 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: INDOLE CARBOXAMIDE DERIVATIVES AND USES THEREOF Filling date: 23 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING BMP6 Filling date: 23 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: PHARMACEUTICAL COMBINATION OF EVEROLIMUS WITH DACTOLISIB Filling date: 23 Sep 2025 Issue date: 4 Feb 2021 |
Application | Utility: DEVICES AND METHODS FOR DETECTING DOSAGE ADMINISTRATION Filling date: 23 Sep 2025 Issue date: 4 Feb 2021 |
Showing 250 to 300 of 676 patents.